BioMark Diagnostics Inc. BMKDF
0.34 USD 0.00 (+0.00%)
At closeNov 4, 2026, 4:00 PM EST
0.3358 Day range 0.3358
0.2259 52-week range 0.5044
- YTD
- -2.07%
- 1 year
- +45.37%
- Market cap
- 35.76M
- EPS (ttm)
- -0.01
- P/E ratio
- -33.58
- YTD return
- -2.07%
- 1-year return
- +45.37%
- Volume
- 200
- Avg volume
- 1.92K
- Open
- 0.3358
- Previous close
- 0.3358
- Day's range
- 0.3358 – 0.3358
- 52-week range
- 0.2259 – 0.5044
2Y +0.1580 (+88.86%)
News
BioMark Announces Participation in upcoming MSACL 2026 and BIOHorizon 2026 Life Sciences Conferences 
BioMark's Metabolomics Platform Captures Global Scientific Interest Following Publications Demonstrating Superior Diagnostic Performance and Cost Efficiency for Liquid Biopsy 
BioMark Diagnostics Endorses Global Call for Equitable Access to Early Screening on 2026 World Lung Cancer Day 
BioMark Diagnostics Secures Landmark Canadian and European Patent Allowances for Early-Stage Lung Cancer Blood Test 
BioMark Secures Broad U.S. Patent for Urine-Based Lung Cancer Screening, Expanding Differentiated Liquid Biopsy Testing Platform 
BioMark Diagnostics to Present Liquid Biopsy Platform at the Canadian Thoracic Society Research Forum 
BioMark Diagnostics Announces Publication of Peer-Reviewed Validation of Machine Learning Models for Lung Cancer Detection in Frontiers in Oncology 
BioMark: 2025 Achievements & 2026 Vision 
BioMark Diagnostics Announces Appointment of Mr. James Lavender to Board of Directors 
BioMark Diagnostics Advances Commercialization Strategy by Initiating ISO 15189 Accreditation Program
Your note
Sign in to keep a note on BMKDF — it syncs with the Stock Master app.